Transcription factors play an important role in the normal development
al process of hematopoietic cells. However, expression of transcriptio
n factors and its implication in various human leukemias is not well u
nderstood. We have studied GATA-1, GATA-2, and stem cell leukemia (SCL
) gene expression in 30 patients with acute myeloid leukemia (AML) by
the reverse transcription-polymerase chain reaction assay. In AML both
GATA-1 and SCL genes were commonly expressed in M6 and M7 leukemias,
and also in leukemias bearing the platelet-associated antigen. We foun
d some AML patients with GATA-1, but not SCL expression. Most CD7(+) A
ML and t(8;21)(q22;q22)-AML were included in this group, which often d
emonstrated immunoglobulin heavy chain and/or T-cell receptor gene rea
rrangements. Consequently, GATA-1(+) SCL(-) AML may originate from ear
ly myeloid progenitors. Moreover, most AML patients of the M3, M4, or
M5 groups were GATA-1(-) SCL(-). Our data suggest that the expression
pattern of transcription factors may help to define distinct phenotype
s of AML cells.